Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Peripheral Nervous System Diseases × sagopilone × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Genitourinary 1

Conditions

Prostatic Neoplasms 2 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1

Interventions

sagopilone 1 pembrolizumab 1 glutamic acid diethyl ester 1 enfortumab vedotin 1 allantoicase 1 Prednisolone 1 Glutamine 1 Glutamic Acid 1 Dietary Supplements 1 BID protein, human 1 Acetylcarnitine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00751205 2014-10-28

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Bayer

Phase 2 Completed

GenitourinaryGynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡